UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 789

Sortiert nach

Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction

European journal of cancer (1990), 2003-02, Vol.39 (3), p.397-404

2003

Volltextzugriff (PDF)

Epithelial Mucin-1 (MUC1) Expression and MA5 Anti-MUC1 Monoclonal Antibody Targeting in Multiple Myeloma

Clinical cancer research, 1999-10, Vol.5 (10), p.3065s-3072s

1999

Volltextzugriff (PDF)

Colonic Tumor CEA, CSAp and MUC-1 Expression following Radioimmunotherapy or Chemotherapy

Tumor biology, 2003-01, Vol.24 (1), p.32-39

2003

Volltextzugriff (PDF)

Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin

International journal of cancer, 1994-04, Vol.57 (2), p.204-210

1994

Volltextzugriff (PDF)

Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors

Cancer research (Chicago, Ill.), 1996-04, Vol.56 (8), p.1805-1816

1996

Volltextzugriff (PDF)

Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4

Cancer research (Chicago, Ill.), 1995-03, Vol.55 (5), p.1105-1110

1995

Volltextzugriff (PDF)

Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer

Clinical cancer research, 2001-10, Vol.7 (10), p.3186-3192

2001

Volltextzugriff (PDF)

Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4

Critical reviews in oncology/hematology, 2001-07, Vol.39 (1), p.147-154

2001

Volltextzugriff (PDF)

Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens

Cancer research (Chicago, Ill.), 1990-02, Vol.50 (3), p.828s-834s

1990

Volltextzugriff (PDF)

Sphingolipid targets in cancer therapy

Molecular cancer therapeutics, 2006-02, Vol.5 (2), p.200-208

2006

Volltextzugriff (PDF)

Microheterogeneity of a purified IgG1 due to asymmetric FAB glycosylation

Molecular immunology, 1992-06, Vol.29 (6), p.751-758

1992

Volltextzugriff (PDF)

Studies on the structure of the organ-specific determinant of human colonic mucin

Molecular immunology, 1989-08, Vol.26 (8), p.769-777

1989

Volltextzugriff (PDF)

Growth inhibition of a rat colon tumor by L-canavanine

Cancer research (Chicago, Ill.), 1986-06, Vol.46 (6), p.2898-2903

1986

Volltextzugriff (PDF)

New MUC1 Serum Immunoassay Differentiates Pancreatic Cancer From Pancreatitis

Journal of clinical oncology, 2006-01, Vol.24 (2), p.252-258

2006

Volltextzugriff (PDF)

Protease digestion of colonic mucin. Evidence for the existence of two immunochemically distinct mucins

The Journal of biological chemistry, 1981-06, Vol.256 (12), p.6354-6358

1981

Volltextzugriff (PDF)

Generation of a monoclonal antibody (G9) reactive with an organ-specific, tumor-associated epitope of human colon carcinoma

Cancer research (Chicago, Ill.), 1989-11, Vol.49 (22), p.6412-6418

1989

Volltextzugriff (PDF)

Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (23 Suppl), p.5743s-5748s

1995

Volltextzugriff (PDF)

Differential Expression of Tumor-Associated Antigens in Human Colon Carcinomas Xenografted Into Nude Mice

JNCI : Journal of the National Cancer Institute, 1983-07, Vol.71 (1), p.117-124

1983

Volltextzugriff (PDF)

Radioimmunotherapy of experimental pancreatic cancer with 131I‐labeled monoclonal antibody PAM4

International journal of cancer, 1997-05, Vol.71 (4), p.660-667

1997

Volltextzugriff (PDF)

Advances in Physical Organic Chemistry

Gold, V

1, 1963

Volltextzugriff (PDF)

Advances in Physical Organic Chemistry

1979

Volltextzugriff (PDF)

Activity of fractionated radioimmunotherapy with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC)

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.240-240

2011

Volltextzugriff (PDF)

Organ specific antigens of the human gastrointestinal tract

Molecular immunology, 1986-10, Vol.23 (10), p.1031-1037

1986

Volltextzugriff (PDF)

Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4115-4115

2010

Volltextzugriff (PDF)

Multicenter study of radiosensitizing gemcitabine combined with fractionated radioimmunotherapy for repeated treatment cycles in advanced pancreatic cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4620-4620

2009

Volltextzugriff (PDF)

1 – 25 von 789

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(673)
Mit Volltextzugriff
(693)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction

Epithelial Mucin-1 (MUC1) Expression and MA5 Anti-MUC1 Monoclonal Antibody Targeting in Multiple Myeloma

Colonic Tumor CEA, CSAp and MUC-1 Expression following Radioimmunotherapy or Chemotherapy

Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin

Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors

Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4

Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer

Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4

Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens

Sphingolipid targets in cancer therapy

Microheterogeneity of a purified IgG1 due to asymmetric FAB glycosylation

Studies on the structure of the organ-specific determinant of human colonic mucin

Growth inhibition of a rat colon tumor by L-canavanine

New MUC1 Serum Immunoassay Differentiates Pancreatic Cancer From Pancreatitis

Protease digestion of colonic mucin. Evidence for the existence of two immunochemically distinct mucins

Generation of a monoclonal antibody (G9) reactive with an organ-specific, tumor-associated epitope of human colon carcinoma

Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer

Differential Expression of Tumor-Associated Antigens in Human Colon Carcinomas Xenografted Into Nude Mice

Radioimmunotherapy of experimental pancreatic cancer with 131I‐labeled monoclonal antibody PAM4

Advances in Physical Organic Chemistry

Advances in Physical Organic Chemistry

Activity of fractionated radioimmunotherapy with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC)

Organ specific antigens of the human gastrointestinal tract

Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC)

Multicenter study of radiosensitizing gemcitabine combined with fractionated radioimmunotherapy for repeated treatment cycles in advanced pancreatic cancer

Suchergebnisse filtern